Education
About Us
Working with TipRanks
Follow Us
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
NASDAQ:GPCR
RESEARCH TOOLSreports
GPCR Analyst Ratings
Strong Buy
12 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
GPCR Stock 12 Month Forecast
Average Price Target
$78.73
▲(273.48%Upside)
| Highest Price Target$120.00 | Average Price Target$78.73 | Lowest Price Target$50.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Guggenheim
$92
Buy
336.43%
Upside
Reiterated
06/25/25
Citizens JMP
$87→$89
Buy
322.20%
Upside
Reiterated
06/23/25
H.C. Wainwright
$75
Buy
255.79%
Upside
Reiterated
06/23/25
Cantor Fitzgerald
$65
Buy
208.35%
Upside
Reiterated
06/22/25
Jefferies
$79
Buy
274.76%
Upside
Reiterated
06/05/25
Piper Sandler
$93
Buy
341.18%
Upside
Reiterated
06/03/25
Morgan Stanley
$118→$120
Buy
469.26%
Upside
Reiterated
05/12/25
Leerink Partners
$60
Buy
184.63%
Upside
Reiterated
05/09/25
William Blair
―
Buy
―
Reiterated
05/09/25
Stifel Nicolaus
$50
Buy
137.19%
Upside
Reiterated
05/09/25
LifeSci Capital
$83
Buy
293.74%
Upside
Reiterated
05/09/25
Citi
$60
Buy
184.63%
Upside
Initiated
05/02/25
BMO Capital
$100
Buy
374.38%
Upside
Reiterated
02/28/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Guggenheim
$92
Buy
336.43%
Upside
Reiterated
06/25/25
Citizens JMP
$87→$89
Buy
322.20%
Upside
Reiterated
06/23/25
H.C. Wainwright
$75
Buy
255.79%
Upside
Reiterated
06/23/25
Cantor Fitzgerald
$65
Buy
208.35%
Upside
Reiterated
06/22/25
Jefferies
$79
Buy
274.76%
Upside
Reiterated
06/05/25
Piper Sandler
$93
Buy
341.18%
Upside
Reiterated
06/03/25
Morgan Stanley
$118→$120
Buy
469.26%
Upside
Reiterated
05/12/25
Leerink Partners
$60
Buy
184.63%
Upside
Reiterated
05/09/25
William Blair
―
Buy
―
Reiterated
05/09/25
Stifel Nicolaus
$50
Buy
137.19%
Upside
Reiterated
05/09/25
LifeSci Capital
$83
Buy
293.74%
Upside
Reiterated
05/09/25
Citi
$60
Buy
184.63%
Upside
Initiated
05/02/25
BMO Capital
$100
Buy
374.38%
Upside
Reiterated
02/28/25
Best Analysts Covering Structure Therapeutics, Inc. Sponsored ADR
1 Month
xxx
Success Rate
10/16 ratings generated profit
Average Return
+7.00%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 62.50% of your transactions generating a profit, with an average return of +7.00% per trade.
3 Months
xxx
Success Rate
8/16 ratings generated profit
Average Return
+10.01%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +10.01% per trade.
1 Year
Success Rate
6/16 ratings generated profit
Average Return
-2.67%
reiterated a buy rating 2 months ago
Copying David Risinger's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -2.67% per trade.
2 Years
xxx
Success Rate
2/15 ratings generated profit
Average Return
-33.48%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 13.33% of your transactions generating a profit, with an average return of -33.48% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
GPCR Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
24
12
13
13
16
Buy
2
2
2
2
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
26
14
15
15
17
Each month's total comprises the sum of three months' worth of ratings.
GPCR Financial Forecast
GPCR Stock Forecast FAQ
What is GPCR’s average 12-month price target, according to analysts?
Based on analyst ratings, Structure Therapeutics, Inc. Sponsored ADR’s 12-month average price target is 78.73.
What is GPCR’s upside potential, based on the analysts’ average price target?
Structure Therapeutics, Inc. Sponsored ADR has 273.48% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is GPCR a Buy, Sell or Hold?
Structure Therapeutics, Inc. Sponsored ADR has a consensus rating of Strong Buy which is based on 12 buy ratings, 0 hold ratings and 0 sell ratings.
What is Structure Therapeutics, Inc. Sponsored ADR’s price target?
The average price target for Structure Therapeutics, Inc. Sponsored ADR is 78.73. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $120.00 ,the lowest forecast is $50.00. The average price target represents 273.48% Increase from the current price of $21.08.
The highest analyst price target is $120.00 ,the lowest forecast is $50.00. The average price target represents 273.48% Increase from the current price of $21.08.
What do analysts say about Structure Therapeutics, Inc. Sponsored ADR?
Structure Therapeutics, Inc. Sponsored ADR’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of GPCR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.